Skip to main content

Phenoxybenzamine Hydrochloride

Generic: PHENOXYBENZAMINE HYDROCHLORIDE

Verified·Apr 23, 2026
Manufacturer
Advanz
NDC
70954-365
ICD-10 indication
C74.10

Affordability Check

How much will you actually pay for Phenoxybenzamine Hydrochloride?

In 30 seconds, see every legitimate way to afford Phenoxybenzamine Hydrochloride — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Phenoxybenzamine Hydrochloride

What is this medication? Phenoxybenzamine Hydrochloride is an alpha-adrenergic blocker primarily used to manage high blood pressure and sweating in patients with pheochromocytoma. This medical condition involves a tumor on the adrenal gland that releases excessive amounts of hormones like adrenaline and noradrenaline. By blocking specific receptors in the blood vessels, the medication helps stabilize blood pressure levels and is most frequently prescribed to prepare patients for surgery to remove the tumor.

The medication works by relaxing and widening the blood vessels, which allows blood to flow more easily and reduces the workload on the heart. Beyond its use before surgery, it may also be employed for the long-term management of symptoms when a tumor cannot be surgically removed. Because the drug can cause a significant drop in blood pressure when changing positions, patients are typically monitored closely by their healthcare provider to ensure the dosage is safe and effective.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Phenoxybenzamine Hydrochloride. Official source: DailyMed (NLM) · Label effective Oct 18, 2022

Indications and usage
INDICATIONS & USAGE Phenoxybenzamine Hydrochloride Capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta -blocking agent concomitantly.
Dosage and administration
DOSAGE & ADMINISTRATION The dosage should be adjusted to fit the needs of each patient. Small initial doses should be slowly increased until the desired effect is obtained or the side effects from blockade become troublesome. After each increase, the patient should be observed on that level before instituting another increase. The dosage should be carried to a point where symptomatic relief and/or objective improvement are obtained, but not so high that the side effects from blockade become troublesome. Initially, 10 mg of phenoxybenzamine hydrochloride twice a day. Dosage should be increased every other day, usually to 20 to 40 mg 2 or 3 times a day, until an optimal dosage is obtained, as judged by blood pressure control. Long-term use of phenoxybenzamine is not recommended (see PRECAUTIONS Carcinogenesis and Mutagenesis).
Contraindications
CONTRAINDICATIONS Conditions where a fall in blood pressure may be undesirable; hypersensitivity to the drug or any of its components.
Warnings
WARNINGS Phenoxybenzamine hydrochloride-induced alpha -adrenergic blockade leaves beta -adrenergic receptors unopposed. Compounds that stimulate both types of receptors may, therefore, produce an exaggerated hypotensive response and tachycardia.
Drug interactions
DRUG INTERACTIONS Phenoxybenzamine hydrochloride may interact with compounds that stimulate both alpha - and beta -adrenergic receptors (i.e., epinephrine) to produce an exaggerated hypotensive response and tachycardia. (See WARNINGS.) Phenoxybenzamine hydrochloride blocks hyperthermia production by levarterenol, and blocks hypothermia production by reserpine.
Adverse reactions
ADVERSE REACTIONS The following adverse reactions have been observed, but there are insufficient data to support an estimate of their frequency. Autonomic Nervous System*: Postural hypotension, tachycardia, inhibition of ejaculation, nasal congestion, miosis. *These so-called "side effects" are actually evidence of adrenergic blockade and vary according to the degree of blockade. Miscellaneous: Gastrointestinal irritation, drowsiness, fatigue. To report SUSPECTED ADVERSE REACTIONS, contact Novitium Pharma, LLC at 1-855-204-1431 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Use in pregnancy
PREGNANCY Teratogenic Effects Adequate reproductive studies in animals have not been performed with phenoxybenzamine hydrochloride. It is also not known whether phenoxybenzamine hydrochloride can cause fetal harm when administered to a pregnant woman. Phenoxybenzamine hydrochloride should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Phenoxybenzamine Hydrochloride appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

14%

762 of 5,509 plans

Most common tier

Tier 5

On 87% of covering formularies

Prior authorization required

27%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)8
11%
Tier 2 (generic)1
1%
Tier 4 (non-preferred brand)1
1%
Tier 5 (specialty)65
87%

Step therapy: 0% of formularies

Quantity limits: 3% of formularies

Coverage breadth: 75 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.